NEW YORK, Nov. 3 (GenomeWeb News) - Ingenuity has licensed its Pathways Analysis technology to the Stanford Genome Technology Center, the company said today.
The Pathways Analysis system maps relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases.
Ron Davis, the director of the Stanford Genome Center, first used the software in beta release, the company said. Davis' lab is collaborating with Ingenuity, of Mountain View, Calif., on developing new functionality to extend its capabilities.
Ingenuity has also recently licensed its Pathways Knowledge database to GlaxoSmithKline, and has signed a software distribution deal with Affymetrix, an investor in the company.